VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia. Clin Cancer Res. 2016 Feb 15; 22(4):868-76.
View in:
PubMed
subject areas
Antineoplastic Agents
Apoptosis
DNA Mutational Analysis
Drug Administration Schedule
Gene Expression
Humans
Imidazolines
Leukemia, Lymphoid
Maximum Tolerated Dose
Proto-Oncogene Proteins c-mdm2
Tumor Suppressor Protein p53
authors with profiles
MICHAEL ANDREEFF